Smith-Magenis syndrome (SMS) is a genetic disorder associated with a distinct phenotype of physical features and neurobehavioral abnormalities due to an interstitial deletion of chromosome 17p11.2 [
1] or mutations in the
RAI1 gene [
2]. Since first described in 1982 [
3], more than 500 persons with SMS have been identified worldwide [
4]. The minimum prevalence of this genetic disorder is estimated to be approximately one in every 25,000 births [
5]. Clinical recognition of the complex physical, developmental, and behavioral features is important for diagnosis. SMS usually is confirmed by detecting the deletion cytogenetically and/or by fluorescence in situ hybridization (FISH[
5]) with genomic probes that contain
RAI1 [
6]. Despite advances in cytogenetic techniques, however, the diagnosis of SMS may be delayed or even missed from lack of clinical awareness of the syndrome and overlap of some identifying characteristics with other genetic disorders [
7].
The characteristic physical features of children and adults with SMS include minor facial dysmorphology, such as brachycephaly, midface hypoplasia, prominent broad forehead, upslanting palpebral fissures, epicanthal folds, broad nasal bridge, and “tented” upper lip [
8]. Hearing impairment, ocular abnormalities, short stature, brachydactyly, and scoliosis also are common [
1,
5,
9].
The neurobehavioral features associated with SMS, described primarily from studies of older children and adults, include mental retardation generally in the mildly to severely delayed range [
1,
9–
14]. Specific cognitive profiles include relative weaknesses in sequential processing, arithmetic, and visual-motor skills and relative strengths in long-term memory, fund of information, and visual-perceptual abilities [
11,
14].
Most children with SMS exhibit deficits in speech and language skills [
1,
4,
15]. Reports suggest that expressive language is more impaired than receptive language [
9,
16,
17], but limited objective data has been published supporting this assertion. Studies also describe pragmatic language deficits [
18] and aberrant voice quality. Otolaryngological abnormalities and oral sensory motor deficits are common and may impact speech [
4,
15].
Common behavioral problems include deficits in all domains of adaptive behavior [
11,
14] with daily living skills and communication significantly more impaired than socialization [
13]. The majority of children with SMS engage in moderate to severe maladaptive behavior [
13,
17,
19,
20], including aggression, temper tantrums, hyperactivity, and stereotypies, such as self-hugging. Furthermore, self-injurious behaviors, such as head-banging, hitting self, hand biting, skin picking, and onychotillomania, are frequent [
9,
13,
17,
19,
20]. Parent reports [
5,
9,
21] and wrist actigraphy [
7,
22,
23] have documented substantial sleep disturbances that are associated with an inverted circadian rhythm of melatonin [
24,
25] and maladaptive behavior [
17,
19]. These behavioral difficulties are considered the most distinctive and problematic characteristic of the syndrome [
17,
19,
26,
27].
To date, no systematic evaluation of a group of children with SMS less than three years of age has been reported. A few prospective studies that included infants did not present the infant data separately [
9,
12,
20]. Currently, the main sources of information regarding the development and behavior of infants and young children with SMS are case reports of very small samples [
1,
10,
29–
32] based primarily on subjective descriptions, retrospective observations, and chart reviews [
1,
10,
30,
32]. These case reports describe global developmental delays, including motor and speech deficits [
7,
10,
15,
29–
32], but age appropriate social skills [
30]. Observations also include decreased overall sleep [
22], lethargy, and placid behavior [
7,
30] in infants, and stereotypic and self-injurious behavioral problems that begin to appear around 18 to 24 months of age [
4,
5,
7,
17,
29,
32]. Systematic, prospective studies of young children using a comprehensive battery of standardized measures are needed to validate these observations, further define the early neurodevelopmental characteristics of SMS, and address longitudinal changes in development. Such information will facilitate earlier clinical diagnosis, effective educational and treatment interventions, and more appropriate management of this disorder, which may lead to improved developmental outcomes [
33].
This study presents objective cross-sectional data collected prospectively from comprehensive multidisciplinary assessments of 11 children with SMS, ages 5 to 35 months, to further delineate the early neurodevelopmental profile of this disorder. Preliminary cross-sectional analyses were conducted to explore the neurodevelopmental characteristics of a younger “infant” subgroup and an older “toddler” subgroup.